XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
CONSOLIDATED STATEMENTS OF OPERATIONS        
Net sales $ 133,920 $ 136,110 $ 260,399 $ 263,452
Cost of sales 124,488 86,663 216,675 164,319
Amortization of intangibles 8,657 8,153 17,246 15,181
Gross profit 775 41,294 26,478 83,952
Operating expenses:        
Research and development expenses 5,644 6,906 12,183 15,846
Selling, general and administrative expenses 13,730 17,421 28,866 38,729
Restructuring expenses   192 4,043 1,580
Asset impairment charges 198,000   198,000 1,618
Total operating expenses 217,374 24,519 243,092 57,773
Operating income (loss) (216,599) 16,775 (216,614) 26,179
Other income (loss):        
Loss on extinguishment of debt       (2,145)
Investment income 43 430 88 1,159
Interest expense (13,496) (16,694) (27,982) (35,986)
Other 28 (735) 5 199
Total other loss (13,425) (16,999) (27,889) (36,773)
Loss before income tax (230,024) (224) (244,503) (10,594)
Income tax benefit (58,076) (5,308) (66,056) (3,521)
Net income (loss) $ (171,948) $ 5,084 $ (178,447) $ (7,073)
Earnings (loss) per common share:        
Basic (in dollars per share) $ (4.36) $ 0.13 $ (4.55) $ (0.18)
Diluted (in dollars per share) $ (4.36) $ 0.13 $ (4.55) $ (0.18)
Weighted average common shares outstanding:        
Basic (in shares) 39,443,441 38,605,052 39,257,211 38,457,159
Diluted (in shares) 39,443,441 40,557,503 39,257,211 38,457,159